vs
Acadia Healthcare Company, Inc.（ACHC）与富兰克林电气（FELE）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是富兰克林电气的1.7倍（$829.0M vs $500.4M），富兰克林电气净利率更高（6.9% vs 0.5%，领先6.4%），富兰克林电气同比增速更快（9.9% vs 7.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -4.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
富兰克林电气是全球知名的水务与能源管理产品及系统制造分销商，主营泵类、电机、驱动器及控制设备，产品广泛应用于住宅、商用、农业、工业、市政等多元场景。公司总部位于美国印第安纳州韦恩堡，在美国、德国、捷克、意大利、土耳其、墨西哥、巴西、澳大利亚、南非等多个国家设有生产基地，为全球客户提供可靠的流体运输与能源管理解决方案。
ACHC vs FELE — 直观对比
营收规模更大
ACHC
是对方的1.7倍
$500.4M
营收增速更快
FELE
高出2.4%
7.5%
净利率更高
FELE
高出6.4%
0.5%
两年增速更快
ACHC
近两年复合增速
-4.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $500.4M |
| 净利润 | $4.5M | $34.7M |
| 毛利率 | — | 35.0% |
| 营业利润率 | — | 9.6% |
| 净利率 | 0.5% | 6.9% |
| 营收同比 | 7.5% | 9.9% |
| 净利润同比 | -50.8% | 10.6% |
| 每股收益（稀释后） | $0.05 | $0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFELE
| Q1 26 | $829.0M | $500.4M | ||
| Q4 25 | $821.5M | $506.9M | ||
| Q3 25 | $851.6M | $581.7M | ||
| Q2 25 | $869.2M | $587.4M | ||
| Q1 25 | $770.5M | $455.2M | ||
| Q4 24 | $774.2M | $485.7M | ||
| Q3 24 | $815.6M | $531.4M | ||
| Q2 24 | $796.0M | $543.3M |
净利润ACHCFELE
| Q1 26 | $4.5M | $34.7M | ||
| Q4 25 | $-1.2B | $39.3M | ||
| Q3 25 | $36.2M | $16.7M | ||
| Q2 25 | $30.1M | $60.1M | ||
| Q1 25 | $8.4M | $31.0M | ||
| Q4 24 | $32.6M | $33.7M | ||
| Q3 24 | $68.1M | $54.6M | ||
| Q2 24 | $78.5M | $59.1M |
毛利率ACHCFELE
| Q1 26 | — | 35.0% | ||
| Q4 25 | — | 33.8% | ||
| Q3 25 | — | 35.9% | ||
| Q2 25 | — | 36.1% | ||
| Q1 25 | — | 36.0% | ||
| Q4 24 | — | 33.8% | ||
| Q3 24 | — | 35.7% | ||
| Q2 24 | — | 36.8% |
营业利润率ACHCFELE
| Q1 26 | — | 9.6% | ||
| Q4 25 | -142.4% | 10.2% | ||
| Q3 25 | 4.7% | 14.6% | ||
| Q2 25 | 5.8% | 15.0% | ||
| Q1 25 | 1.7% | 9.7% | ||
| Q4 24 | 4.9% | 8.9% | ||
| Q3 24 | 12.1% | 13.8% | ||
| Q2 24 | 13.4% | 14.6% |
净利率ACHCFELE
| Q1 26 | 0.5% | 6.9% | ||
| Q4 25 | -143.3% | 7.7% | ||
| Q3 25 | 4.3% | 2.9% | ||
| Q2 25 | 3.5% | 10.2% | ||
| Q1 25 | 1.1% | 6.8% | ||
| Q4 24 | 4.2% | 6.9% | ||
| Q3 24 | 8.4% | 10.3% | ||
| Q2 24 | 9.9% | 10.9% |
每股收益（稀释后）ACHCFELE
| Q1 26 | $0.05 | $0.77 | ||
| Q4 25 | $-12.98 | $0.87 | ||
| Q3 25 | $0.40 | $0.37 | ||
| Q2 25 | $0.33 | $1.31 | ||
| Q1 25 | $0.09 | $0.67 | ||
| Q4 24 | $0.36 | $0.73 | ||
| Q3 24 | $0.74 | $1.17 | ||
| Q2 24 | $0.85 | $1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $80.4M |
| 总债务越低越好 | $2.5B | $134.4M |
| 股东权益账面价值 | $2.0B | $1.3B |
| 总资产 | $5.5B | $2.0B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资ACHCFELE
| Q1 26 | $158.5M | $80.4M | ||
| Q4 25 | $133.2M | $99.7M | ||
| Q3 25 | $118.7M | $102.9M | ||
| Q2 25 | $131.4M | $104.6M | ||
| Q1 25 | $91.2M | $84.0M | ||
| Q4 24 | $76.3M | $220.5M | ||
| Q3 24 | $82.1M | $106.3M | ||
| Q2 24 | $77.2M | $58.1M |
总债务ACHCFELE
| Q1 26 | $2.5B | $134.4M | ||
| Q4 25 | $2.5B | $135.2M | ||
| Q3 25 | $2.3B | $135.2M | ||
| Q2 25 | $2.3B | $14.5M | ||
| Q1 25 | $2.2B | $14.9M | ||
| Q4 24 | $2.0B | $11.6M | ||
| Q3 24 | $1.9B | $11.6M | ||
| Q2 24 | $1.8B | $87.2M |
股东权益ACHCFELE
| Q1 26 | $2.0B | $1.3B | ||
| Q4 25 | $1.9B | $1.3B | ||
| Q3 25 | $3.1B | $1.3B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.3B | ||
| Q3 24 | $3.0B | $1.3B | ||
| Q2 24 | $3.0B | $1.2B |
总资产ACHCFELE
| Q1 26 | $5.5B | $2.0B | ||
| Q4 25 | $5.5B | $1.9B | ||
| Q3 25 | $6.4B | $2.0B | ||
| Q2 25 | $6.3B | $2.0B | ||
| Q1 25 | $6.1B | $1.9B | ||
| Q4 24 | $6.0B | $1.8B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.8B |
负债/权益比ACHCFELE
| Q1 26 | 1.29× | 0.10× | ||
| Q4 25 | 1.28× | 0.10× | ||
| Q3 25 | 0.74× | 0.10× | ||
| Q2 25 | 0.74× | 0.01× | ||
| Q1 25 | 0.72× | 0.01× | ||
| Q4 24 | 0.64× | 0.01× | ||
| Q3 24 | 0.62× | 0.01× | ||
| Q2 24 | 0.62× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCFELE
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $104.2M | ||
| Q3 25 | $73.2M | $102.7M | ||
| Q2 25 | $133.5M | $51.5M | ||
| Q1 25 | $11.5M | $-19.5M | ||
| Q4 24 | $116.7M | $110.3M | ||
| Q3 24 | $163.1M | $116.1M | ||
| Q2 24 | $171.1M | $36.4M |
自由现金流ACHCFELE
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $88.7M | ||
| Q3 25 | $-63.0M | $91.3M | ||
| Q2 25 | $-34.2M | $39.9M | ||
| Q1 25 | $-163.2M | $-26.3M | ||
| Q4 24 | $-86.8M | $97.5M | ||
| Q3 24 | $-27.1M | $106.6M | ||
| Q2 24 | $16.9M | $26.1M |
自由现金流率ACHCFELE
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 17.5% | ||
| Q3 25 | -7.4% | 15.7% | ||
| Q2 25 | -3.9% | 6.8% | ||
| Q1 25 | -21.2% | -5.8% | ||
| Q4 24 | -11.2% | 20.1% | ||
| Q3 24 | -3.3% | 20.1% | ||
| Q2 24 | 2.1% | 4.8% |
资本支出强度ACHCFELE
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.1% | ||
| Q3 25 | 16.0% | 2.0% | ||
| Q2 25 | 19.3% | 2.0% | ||
| Q1 25 | 22.7% | 1.5% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 1.8% | ||
| Q2 24 | 19.4% | 1.9% |
现金转化率ACHCFELE
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.65× | ||
| Q3 25 | 2.02× | 6.14× | ||
| Q2 25 | 4.43× | 0.86× | ||
| Q1 25 | 1.37× | -0.63× | ||
| Q4 24 | 3.58× | 3.28× | ||
| Q3 24 | 2.39× | 2.13× | ||
| Q2 24 | 2.18× | 0.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
FELE
暂无分部数据
